Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02118688Phase 4Withdrawn
A Phase 4 trial of risperidone, trazodone in delirium, sponsored by Rochester General Hospital. Planned start Mar 2011; status: withdrawn.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02118688.